Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU
NORWOOD, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. CRBP ("Corbus" or the "Company"), a precision oncology company with a diversified portfolio, today announced that the Phase 1, first-in-human clinical data from a dose escalation study being carried out by its…
#norwood #mass #corbus #phase1 #mmae #vedotin #padcev #keytruda #cb1 #massachusetts